 |
| |
| Nov-20-17 | Initiated |
H.C. Wainwright |
Buy |
$3 |
|
|
|
| Sep-18-18 08:46AM | Aethlon Medical Receives National Cancer Institute Award PR Newswire |
| Aug-28-18 09:15AM | AEMD: Compassionate Use, Real-World Data, Awaiting FDA Final Guidance Zacks Small Cap Research |
| Aug-27-18 08:00AM | Research Report Identifies Ball, Aethlon Medical, NeoGenomics, Del Taco Restaurants, Arconic, and Agilysys with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
| Aug-08-18 04:15PM | Aethlon Medical Announces First Quarter Fiscal Year 2019 Results PR Newswire |
| 02:30PM | Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE |
| Aug-02-18 08:15AM | Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018 PR Newswire |
| Jun-27-18 09:15AM | Loss-Making Aethlon Medical Inc (NASDAQ:AEMD) Expected To Breakeven Simply Wall St. |
| Jun-25-18 09:15AM | Guy Cipriani Joins Aethlon Medical's Board of Directors PR Newswire |
| Jun-21-18 07:55AM | New Research: Key Drivers of Growth for Nicolet Bankshares, Vitamin Shoppe, Aethlon Medical, Barrett Business Services, Veracyte, and TPG Specialty Lending Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire |
| Jun-13-18 09:30AM | AEMD: AEMD In Active Discussions With FDA Regarding Hemopurifier Pathway Zacks Small Cap Research |
| Jun-08-18 04:15PM | Aethlon Medical Announces Fiscal 2018 Results PR Newswire +5.38% |
| May-31-18 08:45AM | Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018 PR Newswire |
| May-25-18 10:49AM | Are Aethlon Medical Incs (NASDAQ:AEMD) Interest Costs Too High? Simply Wall St. |
| May-01-18 07:55AM | Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical Future Expectations, Projections Moving into 2018 GlobeNewswire |
| Apr-20-18 01:00PM | GVC Capital and Trickle Research Announce Presenter Schedule for Rocky Mountain MicroCap Conference II in Denver on April 24, 2018 ACCESSWIRE |
| Mar-22-18 08:00AM | Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix PR Newswire -7.09% |
| Mar-19-18 08:25AM | Research Report Identifies Chatham Lodging Trust (REIT), Independent Bank Group, NeoGenomics, Black Knight, Aethlon Medical, and PRA Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -11.05% |
| Feb-12-18 06:32AM | Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting PR Newswire +6.94% |
| Feb-06-18 10:00AM | AEMD: Q3 Results. Hemopurifier Pathway Could Benefit From New FDA Mindset Zacks Small Cap Research +9.28% |
| Feb-01-18 04:15PM | Aethlon Medical Announces Fiscal 2018 Third Quarter Results PR Newswire |
| Jan-29-18 08:15AM | Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018 PR Newswire +6.79% |
| Jan-23-18 08:15AM | Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes PR Newswire |
| Jan-19-18 06:05PM | Is It The Right Time To Buy Aethlon Medical Inc (NASDAQ:AEMD)? Simply Wall St. |
| Jan-18-18 07:49AM | Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections PR Newswire |
| Jan-17-18 08:15AM | Market Trends Toward New Normal in FTD Companies, Acuity Brands, MINDBODY, Actinium Pharmaceuticals, XG Technology, and Aethlon Medical Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| Jan-10-18 09:01AM | Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors PR Newswire |
| Jan-07-18 04:18PM | Aethlon Shares Jump Before '60 Minutes' Report On CTE, Vets Benzinga |
| Dec-27-17 07:55PM | How Does Aethlon Medical Incs (NASDAQ:AEMD) Earnings Growth Stack Up Against Industry Performance? Simply Wall St. |
| Nov-29-17 07:45AM | Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board PR Newswire |
| Nov-21-17 10:49AM | What Investors Should Know About Aethlon Medical Incs (AEMD) Financial Strength Simply Wall St. |
| Nov-09-17 12:58PM | Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors PR Newswire +10.82% |
| Nov-08-17 12:00PM | AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research -5.99% |
| Nov-02-17 04:15PM | Aethlon Medical Announces Fiscal 2018 Second Quarter Results PR Newswire |
| 11:00AM | Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE |
| Oct-30-17 07:30AM | Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017 PR Newswire |
| Oct-23-17 08:00AM | AEMD: NCI Cancer Grant, FDAs Real World Data Zacks Small Cap Research |
| Oct-18-17 07:00AM | Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE |
| Oct-16-17 07:15AM | iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire |
| 07:15AM | Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire |
| Oct-12-17 10:14AM | How Does Aethlon Medical Inc (AEMD)s Prospect Stack Up Next To Its Healthcare Peers? Simply Wall St. |
| Oct-11-17 08:15AM | Aethlon Medical to Present at the 2017 BIO Investor Forum PR Newswire |
| Oct-10-17 01:27PM | Aethlon Medical Announces Compliance With Nasdaq Listing Criteria PR Newswire |
| Oct-02-17 06:00AM | Aethlon Medical Announces Pricing of $6 Million Public Offering PR Newswire -37.66% |
| Sep-14-17 07:30AM | Aethlon Medical Receives National Cancer Institute Contract Award PR Newswire |
| Sep-13-17 08:20AM | Today's Research Reports on Stocks to Watch: Aldeyra Therapeutics and Aethlon Medical ACCESSWIRE -12.22% |
| Sep-12-17 07:30AM | Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses PR Newswire +35.13% |
| Sep-11-17 08:51PM | Should You Have Aethlon Medical Incs (AEMD) In Your Portfolio? Simply Wall St. +25.67% |
| Sep-06-17 09:12AM | Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017 PR Newswire +7.38% |
| Aug-21-17 10:00AM | AEMD: EAP Filed, Expect FDA Response By Mid-September Zacks Small Cap Research |
| Aug-11-17 09:02AM | Former NFL Pro Supports Study Of Brain Injuries And Dementia In Football Forbes |
| Aug-10-17 04:15PM | Aethlon Medical Announces Fiscal 2018 First Quarter Results PR Newswire -10.56% |
| 01:00PM | Investor Network: Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE |
| Aug-03-17 07:29PM | ETFs with exposure to Aethlon Medical, Inc. : August 3, 2017 Capital Cube |
| 08:00AM | Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017 PR Newswire |
| Jul-19-17 07:11AM | Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes PR Newswire |
| Jul-07-17 07:00AM | Corporate News Blog - MedShape Divests its ExoShape(R) ACL Product Line to CONMED Accesswire |
| Jul-03-17 02:46PM | ETFs with exposure to Aethlon Medical, Inc. : July 3, 2017 Capital Cube |
| Jun-30-17 03:00PM | AEMD: Feasibility Study Validates Capture, EAP FDA Filing Is Next Zacks Small Cap Research |
| 12:50PM | Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2017 By the Numbers : June 30, 2017 Capital Cube |
| Jun-28-17 04:15PM | Aethlon Medical Announces Fiscal 2017 Results PR Newswire +10.23% |
| Jun-26-17 08:15AM | Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017 PR Newswire |
| Jun-14-17 08:00AM | Aethlon Medical To Present Clinical Study Results at The BIO International Convention PR Newswire +50.00% |
| Jun-06-17 08:00AM | Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017 PR Newswire |
| May-24-17 08:00AM | Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017 PR Newswire -6.24% |
| Apr-28-17 11:00AM | AEMD: Feasibility Study Complete. FDA Discussions Expected To Follow Zacks Small Cap Research |
| Apr-24-17 09:25AM | Aethlon Medical Releases Shareholder Update PR Newswire |
| Apr-04-17 09:03AM | Aethlon Medical Discloses Tech Nation Interview On National Public Radio PR Newswire -19.47% |
| 09:03AM | Aethlon Medical Discloses Tech Nation Interview On National Public Radio |
| Mar-31-17 09:17AM | AETHLON MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of |
| Mar-21-17 02:50PM | AETHLON MEDICAL INC Files SEC form 8-K, Other Events |
| Mar-14-17 05:17PM | AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +6.59% |
| Mar-13-17 07:15AM | Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study PR Newswire +31.74% |
| Mar-08-17 09:25AM | Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017 PR Newswire |
| Mar-01-17 09:25AM | Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes PR Newswire |
| Feb-24-17 09:25AM | Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism PR Newswire |
| Feb-22-17 09:25AM | Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies PR Newswire |
| Feb-16-17 01:04PM | AETHLON MEDICAL INC Financials |
| Feb-15-17 09:00AM | AEMD: FDA Discussions Regarding U.S. Clearance Pathway Zacks Small Cap Research |
| 09:00AM | AEMD: FDA Discussions Regarding U.S. Clearance Pathway |
| Feb-10-17 05:18PM | AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report -9.62% |
| 04:15PM | Aethlon Medical Announces Fiscal 2017 Third Quarter Results PR Newswire |
| 07:07AM | Q3 2017 Aethlon Medical Inc Earnings Release - After Market Close |
| Feb-07-17 04:16PM | AETHLON MEDICAL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar |
| Feb-06-17 09:25AM | Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017 PR Newswire |
| Jan-27-17 11:00AM | AEMD: New CTE Study Largest in Ex-NFL Players |
| Jan-25-17 09:41AM | Aethlon Medical Inc. (AEMD) Readies CTE Blood Diagnostic Trial As Super Bowl LI Approaches at Insider Monkey |
| 07:00AM | Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players PR Newswire |
| Jan-20-17 12:43PM | ETFs with exposure to Aethlon Medical, Inc. : January 20, 2017 |
| Jan-11-17 09:12AM | CEO Note - Clinical Study Update and a Review of 2016 Accomplishments PR Newswire |
| Jan-03-17 12:21PM | ETFs with exposure to Aethlon Medical, Inc. : January 3, 2017 |
| Dec-30-16 03:06PM | AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob |
| Dec-22-16 12:46PM | ETFs with exposure to Aethlon Medical, Inc. : December 22, 2016 |
| Dec-21-16 09:25AM | Passage of the 21st Century Cures Act and its Potential Implications on Biodefense PR Newswire |
| Dec-15-16 09:25AM | Aethlon Announces Initiation of Sepsis-Related Virus Study PR Newswire |
| Dec-08-16 02:09PM | ETFs with exposure to Aethlon Medical, Inc. : December 8, 2016 |
| Nov-16-16 12:33PM | ETFs with exposure to Aethlon Medical, Inc. : November 16, 2016 -9.00% |
| Nov-14-16 11:52AM | Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q2, 2017 By the Numbers : November 14, 2016 |
| Nov-10-16 05:18PM | AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report |
| 04:15PM | Aethlon Medical Announces Fiscal 2017 Second Quarter Results PR Newswire |
| 07:07AM | Q2 2017 Aethlon Medical Inc Earnings Release - After Market Close |
|
|
|
|
| Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Champion Christopher O | SVP, CAO and Controller | Jun 01 | Option Exercise | 0.00 | 1,491 | 0 | 8,505 | Jun 05 04:54 PM | | Leyendecker Ernest A. III | EVP | Jun 01 | Option Exercise | 0.00 | 21,675 | 0 | 43,461 | Jun 05 04:43 PM | | WALKER R A | Chairman, President & CEO | Nov 10 | Option Exercise | 0.00 | 14,951 | 0 | 205,437 | Nov 14 05:58 PM | | REEVES ROBERT K | EVP, Law & CAO | Nov 10 | Option Exercise | 0.00 | 4,674 | 0 | 123,219 | Nov 14 05:52 PM | | Leyendecker Ernest A. III | EVP, Exploration | Nov 10 | Option Exercise | 0.00 | 3,368 | 0 | 23,038 | Nov 14 05:49 PM | | Ingram Mitchell W | EVP, Intl & DW Ops & Proj Mgmt | Nov 10 | Option Exercise | 0.00 | 5,994 | 0 | 31,126 | Nov 14 05:46 PM | | GWIN ROBERT G | EVP, Finance & CFO | Nov 10 | Option Exercise | 0.00 | 5,994 | 0 | 64,408 | Nov 14 05:43 PM | | Champion Christopher O | SVP, CAO and Controller | Nov 10 | Option Exercise | 0.00 | 2,021 | 0 | 7,538 | Nov 14 05:40 PM | | Brown Daniel E | EVP, US Onshore Operations | Nov 10 | Option Exercise | 0.00 | 3,098 | 0 | 21,171 | Nov 14 05:37 PM | | GWIN ROBERT G | EVP, Finance & CFO | Nov 06 | Option Exercise | 0.00 | 3,927 | 0 | 61,050 | Nov 08 04:48 PM | | WALKER R A | Chairman, President & CEO | Nov 06 | Option Exercise | 0.00 | 9,838 | 0 | 194,579 | Nov 08 04:40 PM | | REEVES ROBERT K | EVP, Law & CAO | Nov 06 | Option Exercise | 0.00 | 3,074 | 0 | 119,824 | Nov 08 04:34 PM | | Leyendecker Ernest A. III | EVP, Exploration | Nov 06 | Option Exercise | 0.00 | 1,337 | 0 | 20,220 | Nov 08 04:31 PM | | Brown Daniel E | EVP, US Onshore Operations | Nov 06 | Option Exercise | 0.00 | 1,426 | 0 | 18,456 | Nov 08 04:27 PM | | Ingram Mitchell W | EVP, Intl & DW Ops & Proj Mgmt | Nov 01 | Option Exercise | 0.00 | 19,936 | 0 | 33,482 | Nov 02 04:38 PM | | Brown Daniel E | EVP, US Onshore Operations | Oct 26 | Option Exercise | 0.00 | 2,053 | 0 | 17,564 | Oct 30 05:00 PM | | Champion Christopher O | SVP, CAO and Controller | Oct 26 | Option Exercise | 0.00 | 1,691 | 0 | 5,973 | Oct 30 04:57 PM | | GWIN ROBERT G | EVP, Finance & CFO | Oct 26 | Option Exercise | 0.00 | 5,374 | 0 | 116,381 | Oct 30 04:53 PM | | Leyendecker Ernest A. III | EVP, Exploration | Oct 26 | Option Exercise | 0.00 | 1,932 | 0 | 19,390 | Oct 30 04:48 PM | | REEVES ROBERT K | EVP, Law & CAO | Oct 26 | Option Exercise | 0.00 | 4,191 | 0 | 118,461 | Oct 30 04:44 PM | | WALKER R A | Chairman, President & CEO | Oct 26 | Option Exercise | 0.00 | 13,403 | 0 | 190,213 | Oct 30 04:40 PM | | Holly Bradley J | EVP | Oct 03 | Option Exercise | 0.00 | 31,433 | 0 | 45,768 | Oct 05 05:03 PM |
|
|
|
|
|
|
